No matter how many times it’s been settled throughout history, one of the most basic questions in economics keeps popping up again and again, as if for the first time. Why do things cost what they cost? Once again this question is being pondered, this time by researchers in the field of...

DUBLIN , Dec. 4, 2019 /PRNewswire/ --   Allergan plc (NYSE: AGN) today announced that positive results from ACHIEVE I (UBR-MD-01), a robust Phase 3 clinical trial evaluating the efficacy, safety and tolerability of ubrogepant, have been published in the December 5 th issue of The...

Merger activity remained unchanged with three new deals announced and one deal closing. Deal Statistics: New Deals: The acquisition of TD Ameritrade Holding Corporation (AMTD) by The Charles Schwab Corporation (SCHW) for $26 billion in an all-stock deal. Under the terms of the ag...